Lv11
60 积分 2024-02-05 加入
Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody
8天前
已完结
Blinatumomab: A historical perspective
9天前
已完结
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
9天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
13天前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
14天前
已完结
B-cell Depletion Therapy in Pediatric Neuroinflammatory Disease
18天前
已完结
A new perspective on therapies involving B-cell depletion in autoimmune diseases
18天前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
18天前
已完结
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
18天前
已完结
IL-15/IL-15Rα-Fc fusion protein XmAb24306 potentiates activity of CD3 bispecific antibodies through enhancing T cell expansion
6个月前
已完结
皖公网安备34019202002308
